Adrenergic Cholinergic Enteric Measures/Mapping

Launched by UNIVERSITY OF LOUISVILLE · Jul 8, 2019

Keywords

ClinConnect Summary

This clinical trial, called Adrenergic Cholinergic Enteric Measures/Mapping, is exploring how certain signals in the body might affect conditions related to obesity. Researchers at the University of Louisville are looking to study patients who have symptoms suggesting issues with their autonomic nervous system or digestive system. The trial is currently recruiting participants, and it welcomes individuals aged between 1 and 80 years, regardless of gender.

To be eligible for the trial, participants should have symptoms that indicate possible problems in their body’s automatic functions or digestive processes. However, people with certain conditions, such as a blockage in their digestive tract, being pregnant, or having specific psychiatric disorders that could affect their ability to participate, will not be able to join. If someone decides to participate, they can expect to undergo various assessments related to their symptoms and overall health, contributing to a better understanding of how these body systems relate to obesity.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with the symptoms suggestive of autonomic and/or enteric disorders.
• Exclusion Criteria:
• • Anatomic obstruction of the GI tract
• • Pregnancy
• • Inability of patient or guardian to sign informed consent, if needed
• • Psychiatric disorders precluding assessment and treatment of the patient's GI condition.